Type: announcement

Eli Lilly Secures First International Approval for Weight-Loss Drug Foundayo, Competing with Novo Nordisk’s Wegovy in the U.K.

08/11/2026, 02:37 AM business announcement healthcare
Eli Lilly's weight-loss drug Foundayo has received its first approval for sale in the U.K., positioning it to compete directly with Novo Nordisk's Wegovy pill. This approval is significant as it introduces a second GLP-1 weight-loss option in Europe, potentially expanding the market for oral weight-loss medications.